Applied and Environmental Microbiology, August 1999, p. 3473-3482, Vol. 65, No. 8
0099-2240/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Department of Soil, Water, and Environmental Science, University of Arizona, Tucson, Arizona 85721
Received 26 February 1999/Accepted 26 May 1999
| |
ABSTRACT |
|---|
|
|
|---|
Bioluminescent reporter organisms have been successfully exploited
as analytical tools for in situ determination of bioavailable levels of
contaminants in static environmental samples. Continued characterization and development of such reporter systems is needed to
extend the application of these bioreporters to in situ monitoring of
degradation in dynamic environmental systems. In this study, the
naphthalene-degrading, lux bioreporter bacterium
Pseudomonas putida RB1353 was used to evaluate the relative
influences of cell growth stage, cell density, substrate concentration,
oxygen tension, and background carbon substrates on both the magnitude of the light response and the rate of salicylate disappearance. The
effect of these variables on the lag time required to obtain maximum
luminescence and degradation was also monitored. Strong correlations
were observed between the first three factors and both the magnitude
and induction time of luminescence and degradation rate. The maximum
luminescence response to nonspecific background carbon substrates (soil
extract broth or Luria broth) was 50% lower than that generated in
response to 1 mg of sodium salicylate liter
1. Oxygen
tension was evaluated over the range of 0.5 to 40 mg liter
1, with parallel inhibition to luminescence and
degradation rate (20 mg of sodium salicylate liter
1)
observed at 1.5 mg liter
1 and below and no effect
observed above 5 mg liter
1. Oxygen tensions from 2 to 4 mg liter
1 influenced the magnitude of luminescence but
not the salicylate degradation rate. The results suggest that factors
causing parallel shifts in the magnitude of both luminescence and
degradation rate were influencing regulation of the nah
operon promoters. For factors that cause nonparallel shifts, other
regulatory mechanisms are explored. This study demonstrates that
lux reporter bacteria can be used to monitor both substrate
concentration and metabolic response in dynamic systems. However, each
lux reporter system and application will require
characterization and calibration.
| |
INTRODUCTION |
|---|
|
|
|---|
A major constraint to the development of successful bioremediation technology is the limited ability to quantify bioavailable levels of contaminants to determine whether the concentrations are within the range for potential microbial degradation. There are presently no extraction techniques that are well correlated with bioavailability because current techniques remove some fraction of the sorbed or nonaqueous-phase contaminant which may be physically and chemically unavailable to microbial populations (9, 19, 21, 34). Thus, there is considerable interest in the development of assays that will determine contaminant bioavailability. One such assay uses bioluminescent reporter organisms. In these reporter organisms, the bioluminescence operon (lux) is inserted into biodegradation or resistance pathways of interest so that the lux genes are expressed concurrently and thus can be used to monitor the real-time genetic expression of the pathway of interest. Continued development of this bioluminescent reporter system can meet the urgent need in bioremediation research for tools to not only quantify bioavailable pollutants but also to perform in situ monitoring of degradation in the environment.
Luminescence is produced by the reporter bacterium in a luciferase-catalyzed reaction in response to the oxidation of reduced flavin mononucleotide (FMNH2) and a long-chain aldehyde (15). A number of bioluminescent reporter bacteria have been engineered to quantify bioavailable concentrations of organic contaminants (1, 4, 12, 14, 26, 29, 30, 32) and heavy metals (22, 25). The majority of these organisms use either the luxAB genes encoding the bacterial luciferase or the complete lux operon (luxCDABE), which also encodes the fatty acid reductase complexes required to produce the aldehyde substrate (16, 24). Use of the complete lux operon allows the nondestructive tracking of a specific organism or monitoring of the presence or utilization of organic or heavy-metal compounds in environmental systems without the exogenous addition of the aldehyde substrate. The disadvantage in using the entire operon is that generation of the aldehyde is an ATP- and NADPH-dependent process that not only increases the metabolic load of the cell (5, 10) but also depends upon the channeling of fatty acids into the luminescence system. In addition, for all bioreporters, energy must be diverted to different components of the electron transport system for luminescence production (22). Therefore, the intensity of luminescence can reflect environmental and physiological changes that affect bioreporter metabolic activity.
A number of authors have observed the sensitivity of bioluminescence to various physiological and environmental factors (3, 4, 6, 8, 15, 17, 24). Previous work has also demonstrated the potential for utilization of lux genes for detection in static systems over a small range of concentrations where physiological and environmental conditions can be tightly controlled. For example, Heitzer et al. (7, 8) and Sticher et al. (30) observed a linear relationship between substrate concentration and luminescence, while Rattray et al. (24) and Meikle et al. (18) have looked at the effect of cell density on luminescence. However, no comprehensive studies have been conducted to evaluate the influence of a range of parameters on a single organism. Thus, there remains a need to evaluate physiological and environmental parameters on a broader scale in order to anticipate factors which might cause deviations from the predicted response for applications of the lux bioreporters in situ. In addition, for applications to dynamic systems, it is not enough to consider only the magnitude of luminescence at a specific sample time, as has been done in previous work. Rather, the maximum potential luminescence, the lag time to maximum luminescence, and the relationship of these values to expression of the genes of the regulatory pathway of interest must be understood.
The objective of this research was to conduct a comprehensive overview of the effect of a range of factors on several parameters with a single indicator organism to evaluate the potential use of lux bioreporters as analytical tools or metabolic indicators in a dynamic system such as a saturated flow column. The factors evaluated were cell growth stage, cell density, substrate concentration, oxygen tension, and the interference of potential background carbon substrates from a soil system. Parameters measured included the magnitude of luminescence, the lag time in attaining the maximum response, and the correlation of this response with comparable changes in substrate degradation rates and lag times.
The indicator bioreporter used was Pseudomonas putida RB1353, developed by Burlage et al. (4) and containing two plasmids, the NAH7 plasmid and the constructed nah-lux reporter plasmid, pUTK9. NAH7 is an 83-kb plasmid with genes for naphthalene catabolism in two operons referred to as the upper and lower pathways. The upper pathway degrades naphthalene to salicylate, while the lower pathway is responsible for salicylate metabolism (33). Plasmid pUTK9 is subcloned with a fusion between the promoter from the upper pathway of NAH7 and the luxCDABE genes of Vibrio fischeri (4). Strain RB1353 is an identical sister clone to RB1351 described by Burlage et al. (4a). Burlage et al. (4) demonstrated that light production from RB1351 was directly correlated with naphthalene catabolism and documented a 20-fold increase in light from colonies exposed to naphthalene vapors.
Salicylate was chosen as the substrate for this study because it is responsible for the induction of both nah operons and its high solubility allows investigations of the effects of a wide range of substrate concentrations. Possible inhibitory effects of the lux operon on expression of the nah genes were evaluated by comparison of RB1353 to the parent strain, Pseudomonas putida HK53 (4). Strain HK53 was formed by mating NAH7 into P. putida PB2440.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Bacterial strains and media.
P. putida RB1353 with
stable plasmids NAH7 and pUTK9 (kanamycin resistance) and
Pseudomonas putida HK53 (rifampin resistance), were kindly
supplied by Robert Burlage, Oak Ridge National Laboratories, Oak Ridge,
Tenn., and Gary Sayler, Center for Environmental Biotechnology, University of Tennessee, Knoxville, Tenn., respectively. The strains were maintained in Luria broth (LB) containing 10 g of tryptone, 5 g of yeast extract, and 10 g of NaCl in 1 liter of
deionized H2O with the pH adjusted to 7.0. The medium was
supplemented with either 100 mg of kanamycin sulfate
liter
1 to select for plasmid pUTK9 or 50 mg of rifampin
liter
1 for strain PB2440 as needed. Agar plates were made
by amending LB with 1.5% Bacto Agar (Difco Laboratories, Detroit,
Mich.). Mineral salts broth (MSB), used for growth on sodium
salicylate, contained (in grams per liter)
KH2PO4, 1.5; Na2HPO4,
0.5; MgSO4 · 7H2O, 0.2;
NH4Cl, 2.5; FeCl3, 3 × 10
4;
and CaCl2 · 2H2O, 0.013. Sodium
salicylate and antibiotics were purchased from Sigma Chemical Co., St.
Louis, Mo. Bacterial strains were stored frozen in glycerol (12.5%
glycerol), and fresh cultures were inoculated from these stocks for
each experiment to avoid plasmid loss. Bacterial strains were grown at
24°C with constant shaking at 120 rpm. Cell density was determined
spectrophotometrically at 550 nm with a U-2000 spectrophotometer
(Hitachi Instruments, Inc., Fremont, Calif.) and confirmed by viable
plate counts of serial dilutions.
Cell preparation and experimental design.
Bacteria cells
used for luminescence and salicylate degradation assays were grown in
LB amended with antibiotics appropriate for the individual strain as
specified above. Cultures were inoculated at a density of
104 CFU ml
1 from a 30-h preculture in the
same medium and allowed to grow until the desired growth stage
according to a previously determined growth curve. Growth was
characterized by an initial lag period, logarithmic growth, and a
relatively long deceleration phase followed by stationary and death
phases. Cells were grown in LB prior to transfer to salicylate because
cells grown under these conditions produced a light signal at least
twice the intensity of that produced by cells grown originally in
salicylate. After removal from LB, the cells were washed twice in
saline (0.85% NaCl), resuspended in MSB, and amended with sodium
salicylate. Cultures for each treatment were prepared in triplicate in
250-ml Erlenmeyer flasks with 30 ml of culture per flask and placed on
the shaker. Samples (1 ml) were removed from each flask at each
sampling time and analyzed for luminescence or sodium salicylate.
Quantitation of luminescence and sodium salicylate. (i) Luminescence. Samples (1 ml) were analyzed for luminescence in 7-ml plastic scintillation vials in a 1600TR Tri Carb liquid scintillation analyzer (Packard Instrument Co., Meriden, Conn.). Samples were placed into a vial and immediately counted for 1 min in the single-photon mode, generating relative values expressed in counts per minute. Repeated counting of a single vial or prolonged incubation (longer than 30 min) of samples in plastic vials was avoided because such treatment was found to cause elevated counts compared to those of samples read immediately after removal from culture flasks. Luminescence values obtained at each sampling time were plotted as a function of time, and the peak luminescence value and peak time were recorded for each experiment. Peak time was defined as the time required to attain the maximum luminescence. Alternatively, total luminescence was calculated by integrating under the curve to evaluate the relationship between total luminescence generated and the salicylate degradation rate.
(ii) Salicylate. Salicylate samples (1 ml) were added to 0.5 ml of 1 M NaOH to inhibit further degradation. Before analysis, the samples were centrifuged at 16,000 × g for 10 min to remove cell debris. The sodium salicylate concentrations were then determined from a standard curve by using the U-2000 spectrophotometer at 296 nm and plotted as a function of the sampling time. Degradation curves were characterized by an initial lag followed by a period of increasing degradation rate until the maximum degradation rate (Vmax) was attained with approximately 80% of the initial substrate remaining. A decrease in the degradation rate typically began with 35% of the original substrate remaining. Thus, Vmax was defined as the regression of the linear portion of the degradation curve between 35 and 80% of the original sodium salicylate concentration. Maximum degradation was repeatedly found within this interval regardless of initial substrate concentration. Induction or lag time for salicylate degradation was defined as the time required to degrade the initial 20% of substrate before Vmax was attained.
Growth stage, cell density, and substrate experiments.
Three
series of experiments were conducted with RB1353(pUTK9, NAH7) to
evaluate the influence of growth stage, cell density, and substrate
concentration on the following four parameters: magnitude of
luminescence, peak luminescence time, maximum salicylate degradation
rate (Vmax), and degradation induction time.
Growth stage experiments were conducted with cells from the log,
deceleration, stationary, and death phases obtained from a continuously
growing LB culture as described previously. Cells removed at each
growth stage were washed twice in saline, diluted to a standard
concentration of 107 CFU ml
1 in MSB, amended
with 20 mg of sodium salicylate liter
1, and sampled to
determine the luminescence and degradation rate. The influence of cell
density was evaluated by using 106, 107, and
108 CFU of RB1353 ml
1 obtained from a
stationary-phase LB culture. Cells were exposed to 20 mg of sodium
salicylate liter
1, and luminescence and salicylate
degradation data were determined. Finally, substrate concentration
experiments were conducted in the same way with 107 CFU of
stationary-phase RB1353 cells ml
1. Sodium salicylate was
supplied at a range of concentrations from 0 to 40 mg
liter
1, and data were collected as described previously.
Interference from background carbon substrates.
Luminescence
produced in response to nonspecific carbon substrates was measured to
evaluate potential false signals produced in a dynamic soil system.
Stationary-phase cells were used for all experiments to maximize
potential interference, since cells of this growth phase were found to
produce the strongest luminescence response (see Results). Triplicate
flasks containing 4.5 × 107 CFU of stationary-phase
RB1353 cells ml
1 were exposed to either 20 mg of sodium
salicylate liter
1, 50% LB, or soil extract broth. Soil
extract broth was prepared as described in the Handbook of
Microbiological Media (2) with a sandy loam from an oak
and pine forest in Rose Canyon (Santa Catalina Mountains, Tucson, Az.)
and was diluted 1:1 with MSB. Soil extract was used to evaluate
potential interference produced in response to the presence of soil
organic material as a substrate, and LB was chosen as the rich
substrate preferred for growth of this organism. Luminescence was
monitored for 5 h.
Influence of lux genes on degradation rates. Comparisons were done between P. putida RB1353(NAH7, pUTK9) and the parent strain, P. putida PB2440(NAH7), to evaluate the influence of the lux gene plasmid pUTK9 on salicylate degradation behavior. Simultaneous salicylate degradation assays were conducted as described above with the same cell density and growth stage for both strains. In addition, degradation rates for PB2440 were determined for both deceleration- and stationary-phase cells to evaluate whether changes in cell growth phase had similar effects on Vmax for both RB1353 and PB2440.
DO concentration experiments.
Two series of experiments were
designed to determine the effects of dissolved-oxygen (DO) tension on
the salicylate degradation rate and the corresponding luminescence
response. Stationary-phase cells were used for all experiments,
prepared as described previously, and added to the MSB salicylate (20 mg liter
1) broth to give an approximate cell density of
107 CFU ml
1 for each assay unless stated
otherwise. DO concentrations were determined by using a micro-oxygen
electrode and oxygen meter (Microelectrodes, Inc. Bedford, N.H.).
Calibration was done with buffer sparged with N2 gas and
ambient air for 0- and 8.5-ppm values, respectively.
1, but the large volume and limited surface area in
the flasks containing 225 ml of medium impeded diffusion of air
throughout the medium. Oxygen tension, salicylate concentration, and
luminescence were monitored in samples taken from the flasks throughout
the assay.
The second series of experiments was designed to evaluate the effect of
variations in initial oxygen tension on salicylate degradation and
luminescence. Sterile assay medium was added to 20-ml gas
chromatography vials, which were then sealed with septa. The vials were
then sparged with either sterile O2 or N2 at a constant flow rate for a specific time interval and allowed to equilibrate for 24 h with constant shaking. Variations in sparging time created treatments with oxygen concentrations ranging from 0.5 to
40 mg liter
1. Twelve vials sparged for identical lengths
of time were prepared for each treatment, allowing a single vial to be
sacrificed at each sample time for oxygen, salicylate, and luminescence
measurements. Each vial was inoculated by syringe with 100 µl of
saline cell suspension at the start of the assay, giving an average
cell density of 3.3 × 107 ± 5.4 × 106 CFU ml
1. Three different DO
concentrations were compared for each experiment in addition to an
unsparged control, and the experiment was repeated five times. Since
luminescence and salicylate degradation data change with slight
fluctuations in cell inoculum growth or preparation time, all results
were normalized with respect to the unsparged control assay run during
each experiment to allow comparison of data from all five experiments.
| |
RESULTS AND DISCUSSION |
|---|
|
|
|---|
Growth phase. The growth phase was found to have a significant impact on both the magnitude of the luminescence response and the salicylate degradation rate for strain RB1353 (Fig. 1). Luminescence produced by stationary-phase cells was 1 order of magnitude greater than that produced by deceleration phase cells and 2 orders of magnitude greater than that produced from either log-phase or late-stationary-phase cells. The implications of these results are twofold. First, maximum sensitivity for detection of low substrate concentrations or low cell numbers will be attained in a static system with early-stationary-phase RB1353 cells. As a corollary to this, these results suggest that the effect of growth phase on the lux response should be evaluated for all new lux strains to achieve maximum sensitivity. Second, quantitation of carbon substrate, based on the light response, must take into consideration the growth potential of the cells in a dynamic system. As such, alternate standard curves must be developed for actively growing as opposed to stationary-phase cells. The maximum salicylate degradation rate was also found to vary with growth phase, with maximum rates being detected from logarithmic- and deceleration-phase cells (Fig. 1). The rates decreased with stationary-phase cells and continued to decline as cells entered the death phase. The shortest lag times for both Vmax and peak luminescence corresponded to the growth phase associated with maximum Vmax values (Fig. 1).
|
Cell density. A positive correlation was observed with increasing cell density for both peak luminescence and Vmax (Fig. 2). A particularly good linear correlation was found between peak luminescence and cell number (r2 = 0.9973). Lag times were also affected by changes in biomass. An inverse relationship was observed between cell density and lag times associated with both peak luminescence and Vmax (Fig. 2). Significant shifts in lag time, from 60 to >200 min, were observed in response to 1-log-unit changes in cell counts. Thus, in dynamic systems, changes in cell number will have significant effects on both the magnitude and timing of luminescence and Vmax.
|
Substrate concentration. A strong positive linear correlation was found between substrate concentration and both luminescence (r2 = 0.98) and Vmax (r2 = 0.98) (Fig. 3). Lag times increased for both peak luminescence and Vmax in response to increasing substrate concentration (Fig. 3). Thus, both the magnitude and lag time of peak luminescence and Vmax are affected by substrate concentration.
|
1
but 182 min following exposure to 20 mg liter
1. Further,
the signal generated in response to 20 mg liter
1 at 43 min was lower than that for 1 mg liter
1, while the signal
generated in response to 1 mg of sodium salicylate liter
1
was negligible at 182 min. Although shifts in lag time would be
minimized if the substrate concentration were held within a very
limited range, care must be taken to consider the influence of lag time
on luminescence when analyzing for unknown concentrations.
The strong linear correlation between luminescence and both cell
density and substrate concentration explains the current enthusiastic
exploitation of lux genes as bioreporters, but the associated changes in lag times highlight the fact that these reporters
are living cells, and the use of the assay must not be oversimplified.
The implications of shifting lag times caused by such factors as growth
stage, substrate concentration, and cell density may complicate the use
of the luminescence assay as an analytical tool, but they enhance its
potential use as a metabolic indicator of degradation behavior and,
more specifically, of Vmax. Increases in
mineralization lag time associated with increasing substrate
concentration have been previously documented (27). This
reinforces the hypothesis that the substrate-associated shifts in
luminescence lag time are correlated with, and thus indicators of, the
lag in induction of the nah and sal operons. This
assumption is further corroborated by a similar pattern of increasing
lag time associated with increasing salicylate concentration observed
by using mRNA detection as an index of gene expression (13).
Such parallel behavior demonstrates the unique value of the
lux genes as nonextractive, real-time bioindicators of gene expression, in contrast to lacZY-type systems
(23), which require an extraction and enzyme assay for analysis.
Influence of background carbon substrates.
Experiments were
conducted to evaluate possible false signals generated by nonspecific
carbon sources for application of the luminescence assay to in situ
experiments such as saturated flow soil columns. MSB with no carbon
substrate served as a negative control to indicate background
luminescence levels, and 20 mg of sodium salicylate
liter
1 was the positive control. Maximum luminescence
produced by 4.6 × 107 stationary-phase cells in
response to the nonspecific carbon sources evaluated was less than
0.1% of the signal produced by the same number of cells in response to
20 mg of sodium salicylate liter
1 (Table
1). No significant luminescence was
detected in response to a 5-h incubation with the soil extract broth,
and a maximum increase of 15 times background (from 48 to 749 cpm) was
observed over the 5-h incubation period in the more complex medium,
50% LB. The maximum LB response (749 cpm) was still only half the luminescence peak generated by 55% the number of cells in response to
1 mg of sodium salicylate liter
1 (1,500 cpm [Fig. 3]).
Thus, no significant interference from nonspecific carbon sources is
anticipated during a typical 5-h assay period when analyzing substrate
levels of 1 mg liter
1 or greater.
|
Influence of lux genes on nah gene
expression.
Potential impacts of the lux operon on
expression of the nah genes were evaluated to assess
possible negative aspects to its use as a bioreporter system. In a
simultaneous salicylate degradation assay, the
Vmax for RB1353 was found to be slightly lower
than for the parent strain, PB2440 (2.7 and 3.1 mg liter
1
h
1, respectively), but the difference was insignificant
compared to changes caused by factors such as growth stage, cell
number, and substrate concentration. Growth phase experiments with the parent strain revealed a similar pattern to RB1353, with a higher Vmax observed from deceleration-phase cells than
from stationary-phase cells (data not shown). Thus, the presence of the
pUTK9 plasmid bearing the lux genes does not appear to have
a significant effect on the degradative behavior of the engineered
RB1353 strain under ambient conditions.
DO tension.
Results from the first oxygen experiment (Fig.
4A) show a significant drop in DO tension
during incubation for flasks filled to 90% of capacity, while flasks
filled to 12% maintained a fairly constant oxygen level. The lower
oxygen levels in the former flasks had no effect on salicylate
degradation behavior (Fig. 4B). Limited oxygen availability was most
apparent when consumption was highest, most probably due to reduced
diffusion rates through the liquid media. Diffusion through water is in
the range of 10
5 cm2 s
1,
compared to 10
3 cm2 s
1 for air
(31). In contrast, the luminescence response was enhanced by
the reduced oxygen availability (Fig. 4C). This response was in
contrast to anticipated behavior based on the observation that for two
different luminescent Photobacterium spp., the luciferase reaction required as much as 10 to 20% of the total available oxygen
(6). This competition for oxygen between luciferase and
other metabolic enzymes has been previously identified as a possible
source of complex luminescence behavior (12). A similar enhancement was documented previously in Vibrio fischerii,
the donor organism for the lux genes, but a simultaneous
inhibition of glucose metabolism was also observed. These results led
to the hypothesis that luciferase has a lower Km
value for oxygen and therefore was functioning as a substitute for
cytochrome as the terminal carrier of electrons to oxygen under
microaerophilic conditions (6). However, for RB1353,
substrate degradation was unaffected. Thus, the enhanced luminescence
may be because the slightly reduced conditions in this system enhanced
FMNH2 or aldehyde availability.
|
1 throughout the assay (Fig.
5A). As detailed in Fig. 5B, vials with
initial DO concentrations in the range from 2.5 to 6.2 mg liter
1 maintained fairly constant DO levels. In contrast,
all initial DO treatments at or below 1.5 mg liter
1
resulted in DO levels below 1.0 mg liter
1 by the first
sample time at 70 min (Fig. 5C).
|
1 significantly limited
but did not completely inhibit salicylate degradation, while initial
values of 2.5 mg liter
1 or greater had no effect on
Vmax. Vials with initial DO levels of 1.5 mg
liter
1 showed a slight reduction in
Vmax. As indicated above, DO levels in these
vials dropped below 1.0 mg liter
1 soon after initiation
of the assay. These data suggest that DO levels greater than 1.5 mg
liter
1 must be maintained to support normal degradation
behavior on 20 mg of sodium salicylate liter
1. Some
enhancement of Vmax was observed for treatments
with DO levels greater than ambient (DO > 20 mg
liter
1), but the results were not consistent.
|
1 demonstrated moderate to
severe but not total luminescence inhibition. However, unlike the
Vmax data, luminescence inhibition continued at
2.5 and 3.7 mg liter
1, with normal behavior first
occurring at 5.2 mg liter
1.
Finally, the ratio of total luminescence to Vmax
was calculated and normalized as previously described to evaluate
whether they were similarly inhibited. If the ratio is equal to 1, relative inhibition of Vmax and luminescence are
the same, suggesting that the mechanism of inhibition is the same. If
the ratio is <1, relative inhibition of luminescence is greater,
suggesting that multiple mechanisms of inhibition may be operating. As
shown in Fig. 6C, luminescence is more inhibited for all experiments
with initial DO concentrations less than 5.2 mg liter
1.
Upon closer examination of Fig. 6, it becomes apparent that in all
cases luminescence is more inhibited than Vmax
but that at low initial DO levels (<1.5 mg liter
1) both
processes are substantially inhibited. Therefore, we suggest that a
separate mechanism of inhibition exists for experiments with initial DO
concentrations of 2.5 and 3.7 mg liter
1 while a combined
mechanism of inhibition operates at levels less than or equal to 1.5 mg
liter
1.
The decreased luminescence at initial DO levels from 2.5 to 3.7 mg
liter
1 could be attributed to insufficient oxygen, but
this explanation conflicts with observed results from the first study,
where enhanced luminescence was observed in flasks where DO levels
decreased to levels within the range from 3.5 to 5.5 mg
liter
1 (Fig. 4). This observation emphasizes the fact
that the critical factor is the initial DO level, not the DO level at
the time the luminescence is expressed.
Regulation of biodegradation and luminescence expression.
One
possible explanation for the observed effects of substrate and oxygen
concentration on salicylate degradation and luminescence behavior can
be found through an evaluation of the nahR regulatory system
in combination with general bacterial global regulatory mechanisms.
Bacterial cells must be able to adapt rapidly to a wide range of
fluctuations in environmental conditions in order to survive. An
important survival strategy involves the meticulous control of numerous
operons to avoid the waste of energy resulting from the synthesis of
excess mRNA or enzymes (28). Expression of the
sal and lux genes in RB1353 is controlled by the
lower-pathway promoter, Psal, and the upper-pathway
promoter, Pnah, respectively (4). Both promoters
have a site at bp
70 preceding the transcription start site that is
recognized by the nahR gene regulatory protein (4). The nahR gene is transcribed constitutively,
but the NahR protein is activated (NahRa) only following binding to the
inducer, salicylate. Subsequent NahRa-concentration-dependent 10- to
50-fold increases in production of nah enzymes have been
observed (33). Thus, it is logical that a linear
relationship was observed between substrate concentration and both
Vmax and luminescence.
1
is attributed to regulated induction rather than constitutive expression because of the magnitude of the observed luminescence. Maximum constitutive expression of the lux genes (749 cpm),
as determined by growth in rich medium (Table 1), is still more than 5 times lower than the peak luminescence generated from the lowest
initial DO treatment of 0.5 mg liter
1 (3,904 cpm).
Alternatively, this observed behavior could be attributed to a global
regulatory system which exists to help a cell sense and respond to its
redox environment in order to repress excess enzyme production at low
oxygen levels. Such global mechanisms, which monitor cellular oxidative
conditions and respond by adjusting the expression of a range of
operons, have been identified in both E. coli
(11) and Bacillus subtilis (20). One
global mechanism identified in E. coli is the ArcAB (aerobic
respiration control) system, a two-component system containing a sensor
membrane protein and a DNA binding protein known to repress 17 and
activate 9 operons. ArcA is a repressor whose DNA binding activity is
stimulated following transphosphorylation by the sensor protein, ArcB,
in response to reduced oxygen conditions. Such a two-component system
could be functioning in RB1353, where an activated repressor protein such as ArcA competes with NahRa for the Psal and
Pnah binding sites, thus repressing the induction rate of
nah and lux genes. ResDE, a similar two-component
signal transduction system, has been identified in B. subtilis. The ResDE system also plays an essential role in
altering metabolic activity by regulating operons in response to oxygen
availability (20).
An alternate mechanism could involve the global regulation of plasmid
copy number in response to the cell redox potential. NAH7 is a large,
low-copy-number plasmid, while pUTK9 is a smaller plasmid with a higher
copy number (4). Thus, a greater potential exists for
fluctuations in pUTK9 copy number, creating a subsequent effect on
lux enzyme production. Although the plasmid copy number must
be considered a potential factor influencing lux enzyme
expression, no evidence currently exists for global regulation of
plasmid copy number in response to cell redox potential, as has been
found with the regulation of metabolic activity by the two-component systems described.
The ArcAB-type, two-component global regulatory system could also
explain the conflicting luminescence results observed for DO tensions
in the range from 3.5 to 5.5 mg liter
1 depending on the
initial DO concentration in the experiment. Under the initial DO
tensions of 3.5 to 5.5 mg liter
1 established in the
second series of oxygen experiments, the reduced luminescence response
could not be attributed to regulation of the sal and
nah operons, since a parallel response was not observed in
the Vmax data. However, alternate operons in the
cell may have been partially repressed, affecting the availability of
essential components for the luciferase reaction such as
FMNH2 or the fatty acids required for conversion to the
long-chain aldehyde. The FMN reductase, for example, is not subject to
coinduction with luciferase (6) and thus could be regulated
at a different rate. The ArcAB system in E. coli represses
basic enzymes essential for aerobic respiration such as components of
the tricarboxylic acid cycle (11) under conditions of
limited oxygen availability. In contrast, production of such reaction
components would not have been repressed at the initial DO levels of
8.5 mg liter
1 established in the first oxygen experiment.
Even if the relevant pathways became repressed as the oxygen levels
decreased in the 90% full flasks, the cell would have accumulated
enough of the reaction components during the initial portion of the
assay to maintain the enhanced levels of luminescence observed for a
limited period.
In conclusion, the oxygen data demonstrates that in the presence of 20 mg of sodium salicylate liter
1, both luminescence and
degradation in RB1353 are inhibited by initial DO tensions of 1.5 mg
liter
1 or less. The majority of this inhibition can be
attributed to regulated induction of the nah and
sal promoters, but part of the luminescence inhibition is
specific to the luciferase reaction itself, possibly associated with
availability of reaction components as discussed above. At oxygen
tensions from 2 to 4 mg liter
1, a slight repression in
luminescence response can be expected despite normal degradation
behavior if the cell has experienced this redox level for an extended
period. Alternatively, if the cell experiences a sharp drop in
available oxygen, an enhanced luminescence response can be expected
over the same general oxygen range. At oxygen levels of 5.5 mg
liter
1 or greater, the luminescence response to 20 mg of
sodium salicylate liter
1 would follow the predicted
behavior. Thus, care must be taken to monitor DO levels in a dynamic
system and to identify the DO threshold below which luminescence
response is inhibited. Although inhibition of luminescence may be
greater than of Vmax at low DO concentrations,
luminescence can still be used as an indicator of degradation
inhibition in a dynamic system where oxygen is potentially limiting.
The present research demonstrates the value of lux
bioreporters as tools not only to monitor real-time expression of
specific pathways but also as indicators of metabolic activity in
bacterial cells in response to changes in environmental conditions.
More extensive work can be done to specifically model the influence on
luminescence of a specific combination of environmental or physiological cell conditions which may be in flux in a dynamic system,
but the model must be organism and application specific. Despite the
necessity for such preliminary work, the possibilities offered by such
luminescent reporters are extensive and unique.
| |
ACKNOWLEDGMENT |
|---|
This research was supported by grant DEB-9523870 from the National Science Foundation.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: 429 Shantz Building, Department of Soil, Water, and Environmental Science, University of Arizona, P.O. Box 210038, Tucson, AZ 85721-0038. Phone: (520) 621-7231. Fax: (520) 621-1647. E-mail: rmaier{at}ag.arizona.edu.
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Applegate, B. M.,
S. R. Kehrmeyer, and G. S. Sayler.
1998.
A chromosomally based tod-luxCDABE whole-cell reporter for benzene, toluene, ethylbenzene, and xylene (BTEX) sensing.
Appl. Environ. Microbiol.
64:2730-2735 |
| 2. | Atlas, R. M. 1993. Handbook of microbiological media. CRC Press, Inc., Boca Raton, Fla. |
| 3. | Blouin, K., S. G. Walker, J. Smit, and R. F. B. Turner. 1996. Characterization of in vivo reporter systems for gene expression and biosensor applications based on luxAB luciferase genes. Appl. Environ. Microbiol. 62:2013-2021[Abstract]. |
| 4. |
Burlage, R. S.,
G. S. Sayler, and F. Larimer.
1990.
Monitoring of naphthalene catabolism by bioluminescence with nah-lux transcriptional fusions.
J. Bacteriol.
172:4749-4757 |
| 4a. | Burlage, R. S., et al. Personal communication. |
| 5. |
de Weger, L. A.,
P. Dunbar,
W. F. Mahafee,
B. J. J. Lugtenberg, and G. S. Sayler.
1991.
Use of bioluminescence markers to detect Pseudomonas spp. in the rhizosphere.
Appl. Environ. Microbiol.
57:3641-3644 |
| 6. | Hastings, J. W., C. J. Potrikus, S. C. Gupta, M. Kurfurst, and J. C. Makemson. 1985. Biochemistry and physiology of bioluminescent bacteria. Adv. Microb. Physiol. 26:235-291[Medline]. |
| 7. |
Heitzer, A.,
K. Malachowsky,
J. E. Thonnard,
P. R. Bienkowski,
D. C. White, and G. S. Sayler.
1994.
Optical biosensor for environmental on-line monitoring of naphthalene and salicylate bioavailability with an immobilized bioluminescent catabolic reporter bacterium.
Appl. Environ. Microbiol.
60:1487-1494 |
| 8. |
Heitzer, A.,
O. F. Webb,
J. E. Thonnard, and G. S. Sayler.
1992.
Specific and quantitative assessment of naphthalene and salicylate bioavailability by using a bioluminescent catabolic reporter bacterium.
Appl. Environ. Microbiol.
58:1839-1846 |
| 9. | Herman, D. C., Y. Zhang, and R. M. Miller. 1997. Rhamnolipid (biosurfactant) effects on cell aggregation and biodegradation of residual hexadecane under saturated flow conditions. Appl. Environ. Microbiol. 63:3622-3627[Abstract]. |
| 10. | Hill, P. J., C. E. D. Rees, M. K. Winson, and G. S. A. B. Stewart. 1993. The application of lux genes. Biotechnol. Appl. Biochem. 17:3-14. |
| 11. |
Iuchi, S., and L. Weiner.
1996.
Cellular and molecular physiology of Escherichia coli in the adaptation to aerobic environments.
J. Biochem.
120:1055-1063 |
| 12. |
King, J. M. H.,
P. M. DiGrazia,
B. Applegate,
R. Burlage,
J. Sanseverino,
P. Dunbar,
F. Larimer, and G. S. Sayler.
1990.
Rapid sensitive bioluminescent reporter technology for naphthalene exposure and biodegradation.
Science
249:778-781 |
| 13. | Marlowe, E. M., R. M. Maier, and I. L. Pepper. 1999. An RT-PCR assay for evaluating gene expression as an index of biodegradation. J. Microbiol. Methods submitted. |
| 14. | Masson, L., Y. Comeau, R. Brousseau, R. Samson, and C. Greer. 1993. Construction and application of chromosomally integrated lac-lux gene markers to monitor the fate of a 2,4-dichlorophenoxyacetic acid-degrading bacterium in contaminated soils. Microb. Releases 1:209-216[Medline]. |
| 15. | Meighen, E. A. 1988. Enzymes and genes from the lux operons of bioluminescent bacteria. Annu. Rev. Microbiol. 42:151-176. |
| 16. |
Meighen, E. A.
1991.
Molecular aspects of bacterial bioluminescence.
Microbiol. Rev.
55:123-142 |
| 17. | Meikle, A., L. A. Glover, K. Killham, and J. I. Prosser. 1994. Potential luminescence as an indicator of activation of genetically-modified Pseudomonas fluorescens in liquid culture and in soil. Soil Biol. Biochem. 26:747-755. |
| 18. | Meikle, A., K. Killham, J. I. Prosser, and L. A. Glover. 1992. Luminometric measurement of population activity of genetically modified Pseudomonas fluorescens in the soil. FEMS Microbiol. Lett. 99:217-220. |
| 19. | Miller, R. M. 1995. Surfactant-enhanced bioavailability of slightly soluble organic compounds, p. 33-54. In H. Skipper, and R. Turco (ed.), Bioremediation science and applications. Soil Science Society of America, Madison, Wis. |
| 20. | Nakano, N. M., and P. Zuber. 1998. Anaerobic growth of a "strict aerobe" (Bacillus subtilis). Annu. Rev. Microbiol. 52:165-190[Medline]. |
| 21. | National Research Council. 1993. In situ bioremediation: when does it work? National Academy Press, Washington, D.C. |
| 22. | Patton, G. I., C. D. Campbell, L. A. Glover, and K. Killham. 1995. Assessment of bioavailability of heavy metals using lux modified constructs of Pseudomonas flourescens. Lett. Appl. Microbiol. 20:52-56. |
| 23. |
Ramanathan, S.,
W. P. Shi,
B. P. Rosen, and S. Daunert.
1998.
Bacteria-based chemiluminescence sensing system using -galactosidase under the control of the ArsR regulatory protein of the ars operon.
Anal. Chim. Acta
369:189-195.
|
| 24. |
Rattray, E. A. S.,
J. I. Prosser,
K. Killham, and L. A. Glover.
1990.
Luminescence-based nonextractive technique for in situ detection of Escherichia coli in soil.
Appl. Environ. Microbiol.
56:3368-3374 |
| 25. |
Selifonova, O. V.,
R. Burlage, and T. Barkay.
1993.
Bioluminescent sensors for detection of bioavailable Hg(II) in the environment.
Appl. Environ. Microbiol.
59:3083-3090 |
| 26. | Selifonova, O. V., and R. W. Eaton. 1996. Use of ibp-lux fusion to study regulation of the isopropylbenzene catabolism operon of Pseudomonas putida RE204 and to detect hydrophobic pollutants in the environment. Appl. Environ. Microbiol. 62:778-783[Abstract]. |
| 27. |
Simkins, S., and M. Alexander.
1984.
Models for mineralization kinetics with the variables of substrate concentration and population density.
Appl. Environ. Microbiol.
47:1299-1306 |
| 28. | Snyder, L., and W. Champness. 1997. Molecular genetics of bacteria. American Society for Microbiology, Washington, D.C. |
| 29. | Stewart, G. S. A. B., and P. Williams. 1992. lux genes and the applications of bacterial luminescence. J. Gen. Microbiol. 138:1289-1300[Medline]. |
| 30. | Sticher, P., M. C. M. Jaspers, K. Stemmler, H. Harms, A. J. B. Zehnder, and J. R. van de Meer. 1997. Development and characterization of a whole-cell bioluminescent sensor for bioavailable middle-chain alkanes in contaminated ground water samples. Appl. Environ. Microbiol. 63:4053-4060[Abstract]. |
| 31. | Tiedje, J. M. 1988. Ecology of denitrification and dissimilatory nitrate reduction to ammonium in biology of anaerobic microorganisms, p. 179-244. In A. J. B. Zehnder (ed.), Biology of anaerobic microorganisms. John Wiley & Sons, Inc., New York, N.Y. |
| 32. |
Willardson, B. M.,
J. F. Wilkins,
T. A. Rand,
J. M. Schupp,
K. K. Hill,
P. Keim, and P. J. Jackson.
1998.
Development and testing of a bacterial biosensor for toluene-based environmental contaminants.
Appl. Environ. Microbiol.
64:1006-1012 |
| 33. | Yen, K., and C. M. Serdar. 1988. Genetics of naphthalene catabolism in pseudomonads. Crit. Rev. Microbiol. 15:247-268[Medline]. |
| 34. |
Zhang, Y., and R. M. Miller.
1992.
Enhanced octadecane dispersion and biodegradation by a Pseudomonas rhamnolipid surfactant (biosurfactant).
Appl. Environ. Microbiol.
58:3276-3282 |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| J. Bacteriol. | Microbiol. Mol. Biol. Rev. | Eukaryot. Cell | All ASM Journals |
|---|